BIOLASE Issued Broad New Patent for Treating Eye Conditions, Including Presbyopia, Cataracts and Glaucoma

IRVINE, CA–(Marketwire -11/30/11)- BIOLASE Technology, Inc. (NASDAQ: BLTI – News), a World’s heading dental laser manufacturer and distributor, currently announced that a U.S. Patent and Trademark Office has released BIOLASE a new obvious covering a use of a laser technologies for treating several conditions of a eye. The obvious covers a design and techniques for treating an visible or associated hankie site utilizing laser appetite to impact one or some-more physiological properties mitigating a effects of presbyopia and improving a approach a chairman sees.

Patent 8,056,564 is patrician “Methods for Treating Eye Conditions” and supports a ophthalmic patents previously

Article source: http://finance.yahoo.com/news/BIOLASE-Issued-Broad-New-iw-2876389802.html

BIOLASE to Present during Upcoming Investment Conferences

IRVINE, CA–(Marketwire -11/29/11)- BIOLASE Technology, Inc. (NASDAQ: BLTI – News), a World’s heading dental laser manufacturer and distributor, announced currently that government is scheduled to make financier presentations during dual arriving investment conferences.

The initial discussion will be CANACCORD Genuity’s 6th Annual Cardiovascular, Aesthetics Metabolic Disorders Conference on Tuesday, Dec 6, during that COO and CFO Fred Furry is scheduled to benefaction during 10:00 am Pacific Time. The one-day discussion is being hold during a St. Regis Hotel in San Francisco.

A live audio webcast of a display during a CANACCORD Genuity Conference will be accessible in

Article source: http://finance.yahoo.com/news/BIOLASE-Present-Upcoming-iw-1863038741.html

BIOLASE Declares Stock Dividend for 2011 Fourth Quarter

IRVINE, CA–(Marketwire – Nov 15, 2011) – BIOLASE Technology, Inc. (NASDAQ: BLTI), a World’s heading dental laser manufacturer and distributor, currently announced that a Board of Directors has announced a 1 percent batch division payable on Dec 5, 2011, to stockholders of record on Nov 25, 2011.

About BIOLASE Technology, Inc.
BIOLASE Technology, Inc., a World’s heading Dental Laser Company, is a medical record association that develops, manufactures and markets dental lasers and also distributes and markets dental imaging equipment, products that are focused on technologies that allege a use of dentistry and medicine. The Company’s laser products incorporate

Article source: http://www.marketwire.com/mw/release.do?id=1587086&sourceType=3

BIOLASE to Present during Lazard Capital Markets Healthcare Conference

IRVINE, CA–(Marketwire -11/09/11)- BIOLASE Technology, Inc. (NASDAQ: BLTI – News), a World’s heading dental laser manufacturer and distributor, announced currently that COO CFO Fred Furry is scheduled to make an financier display during Lazard Capital Markets 8th Annual Healthcare Conference on Wednesday, Nov 16, during 2:30 pm Eastern Time. The discussion is being hold Nov 15-16 during a Pierre Hotel in New York City.

About BIOLASE Technology, Inc.
BIOLASE Technology, Inc., a World’s heading Dental Laser company, is a medical record association that develops, manufactures and markets dental lasers and also distributes and markets dental imaging equipment, products

Article source: http://finance.yahoo.com/news/BIOLASE-Present-Lazard-iw-1667381731.html

BIOLASE Granted Regulatory Approval to Sell Waterlase iPlus(TM) All-Tissue Dental Laser Systems in South Korea

IRVINE, CA–(Marketwire – Nov 8, 2011) – BIOLASE Technology, Inc. (NASDAQ: BLTI), a World’s heading dental laser manufacturer and distributor, announced now that it has perceived capitulation from a Korean Food and Drug Administration (“KFDA”) to sell a Waterlase iPlus™ all-tissue dental laser systems via South Korea. South Korea has an estimated 25,000 dentists and 16,000 dental clinics, and their on-going dental practitioners have been quite disposed to adopting high-tech dental equipment, including some-more than 1,000 practices that now use one or some-more BIOLASE dental lasers.

Chairman and CEO Federico Pignatelli said, “The regulatory capitulation of a iPlus in Korea is

Article source: http://www.marketwire.com/mw/release.do?id=1583665&sourceType=3

BIOLASE Chief Financial Officer Frederick D. Furry to Add Chief Operating Officer Role

IRVINE, CA–(Marketwire – Oct 19, 2011) – BIOLASE Technology, Inc. (NASDAQ: BLTI), a World’s heading dental laser manufacturer and distributor, announced currently that Chief Financial Officer Frederick D. Furry has been allocated to Chief Operating Officer, effective immediately. Furry will continue in his purpose as Chief Financial Officer and reports directly to Chief Executive Officer Federico Pignatelli.

“Fred has been instrumental in a turnaround efforts during BIOLASE over a past year, and broadening his responsibilities to embody operations will concede him to move even some-more value to a organization,” pronounced Pignatelli. “Both we and a Board have each certainty that Fred’s

Article source: http://www.marketwire.com/mw/release.do?id=1575147&sourceType=3

BioLase says CFO Furry will also turn COO

IRVINE, Calif. (AP) — Dental laser association BioLase Technology Inc. pronounced Wednesday that Chief Financial Officer Frederick Furry is apropos a arch handling officer.

The company pronounced Furry, 43, will continue as CFO. He assimilated a association in Nov after 18 years operative during accounting firms.

Earlier this week a association allocated Richard Whipp to a newly combined post of vice boss of operations.

Shares of BioLase Technology fell 15 cents, or 4.2 percent, to $3.42 in morning trading. Over a past year, shares have traded between $1.16 and $6.78.

Article source: http://news.yahoo.com/biolase-says-cfo-furry-become-coo-153205509.html